Figure 8.
UHPLC-ESI-MS/MS chromatogram of CGA and toosendanin (TSN). (A) Negative Scan m/z 100–500 of CGA; (B) MS/MS spectrum of m/z 353.10 in the negative ion mode; (C) Negative Scan m/z 100–700 of TSN; (D) MS/MS spectrum of m/z 573.10 in the negative ion mode; (E) MRM of channels ESI− 353.10/191.15 and 353.10/161.10 for blank CSF sample; (F) MRM of channels ESI− 353.10/191.15 and 353.10/161.10 for CSF spiked with CGA; (G) MRM of channels ESI− 573.15/531.15 for blank CSF sample; (H) MRM of channels ESI− 573.15/531.15 for CSF spiked with TSN. Notes: Chromatographic conditions are provided in the Experimental Section.